
Daljeet Kohli’s experience with Ajanta Pharma and Shilpa Medicare shows that it is not enough to identify winning stocks. To reap the full benefit, we must have the sagacity to remain invested inspite of temporary periods of over-valuation and adversities
Recent Comments